Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders

NCT00176826 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT00176826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00176826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Phase 2/3
Overall status
Terminated
Start date
September 30, 2000
Completion date
August 31, 2015
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chediak-higashi syndrome, griscelli syndrome, hematologic diseases, hemophagocytic lymphohistiocytosis, immunologic diseases, langerhans-cell histiocytosis, x-linked lymphoproliferative disorders